Patterns of lymphadenopathy in thoracic malignancies

Area of Science:

• Thoracic oncology
• Radiology
• Pathology

Background:

• Lymphatic drainage pathways in the thorax are critical for staging various thoracic cancers, including lung, breast, lymphoma, esophageal, and mesothelioma.
• Accurate identification of nodal stations draining primary thoracic tumors is essential for detecting metastatic spread.
• Size criteria alone are insufficient for predicting nodal status, necessitating pathologic confirmation.

Purpose of the Study:

• To emphasize the importance of understanding thoracic lymphatic drainage for accurate cancer staging.
• To highlight the role of imaging modalities in evaluating nodal status and guiding interventions.
• To underscore the necessity of identifying relevant lymph node regions in relation to primary tumors for comprehensive cancer assessment.

Main Methods:

• Computed tomography (CT) assists in determining optimal nodal sampling approaches.
• Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) detects diseased lymph nodes not apparent on CT alone.
• Image fusion of FDG PET with CT enhances the detection of metastatic lymphadenopathy.

Main Results:

• Radiologic imaging, including CT and FDG PET-CT, plays a crucial role in initial staging.
• Imaging guides surgical and interventional radiologists in nodal sampling procedures.
• FDG PET-CT improves the detection of abnormal lymph nodes, especially when fused with CT.

Conclusions:

• Accurate staging of thoracic cancers relies on a thorough understanding of lymphatic pathways and nodal stations.
• Radiologic imaging is indispensable for initial staging, guiding interventions, posttreatment assessment, and detecting recurrent disease.
• Pathologic confirmation remains essential for accurate nodal status determination, complementing imaging findings.